CIBC World Markets’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-147,000
Closed -$5.39M 724
2022
Q4
$5.39M Buy
+147,000
New +$5.81M 0.04% 312
2021
Q3
Sell
-106,000
Closed -$9.49M 637
2021
Q2
$9.49M Buy
106,000
+97,125
+1,094% +$8.21M 0.07% 173
2021
Q1
$673K Buy
+8,875
New +$669K ﹤0.01% 719

Other funds holding SYNH

CIBC World Markets's SYNH Position: Q1 2023 in Review

CIBC World Markets sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 147,000 shares — an estimated $5.39M sold.

CIBC World Markets first reported a position in SYNH in Q1 2021 and held it in 3 quarters. The position peaked at $9.49M in Q2 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • CIBC World Markets reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • CIBC World Markets sold 147,000 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $5.39M.
  • CIBC World Markets first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 3 quarters.
  • CIBC World Markets's Syneos Health, Inc. Class A Common Stock position peaked at $9.49M in Q2 2021.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on CIBC World Markets's 13F filing for Q1 2023, filed 11 May 2023.